| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.7M | — |
| Cost of Revenue | $4.1M | — |
| Gross Profit | $2.6M | — |
| R&D Expense | $9.3M | +14.2% |
| SG&A Expense | $8.3M | +60.3% |
| Operating Income | -$15.1M | -12.8% |
| Interest Expense | $127K | — |
| Pre-tax Income | -$14.9M | -15.8% |
| Income Tax | $0 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.3M | +90.3% |
| Short-term Investments | $9.7M | -61.0% |
| Accounts Receivable | $418K | +214.1% |
| Current Assets | $34.1M | -15.8% |
| Total Assets | $46.8M | -12.5% |
| Current Liabilities | $3.0M | +27.3% |
| Long-term Debt | $6.4M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.4M | +5.4% |
| Capital Expenditures | $10.3M | — |
| Investing Cash Flow | $14.7M | +142.0% |
| Financing Cash Flow | $6.3M | -87.3% |
| Free Cash Flow | -$20.7M | -87.4% |
| Net Income | -$14.9M | -15.8% |
| EPS (Basic) | -$0.42 | +39.1% |
| EPS (Diluted) | -$0.42 | +39.1% |
| Total Liabilities |
| $9.4M |
| +304.1% |
| Stockholders' Equity | $37.4M | -26.9% |